Dieses Ergebnis aus ScienceDirect kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

Title:	Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Authors:	Borchmann, Peter ^{a, b, c, d, *}; Ferdinandus, Justin ^{a, b, c, d}; Schneider, Gundolf ^{a, b, c, d}; Moccia, Alden ^{e, f}; Greil, Richard ^{g, h, i}; Hertzberg, Mark ^{j, k}; Schaub, Valdete ^l; Hüttmann, Andreas ^m; Keil, Felix ⁿ; Dierlamm, Judith ^o; Hänel, Mathias ^p; Novak, Urban ^{e, q}; Meissner, Julia ^r; Zimmermann, Andreas ^s; Mathas, Stephan ^{t, u, v, w}; Zijlstra, Josée M ^x; Fosså, Alexander ^{y, z}; Viardot, Andreas ^aa; Hertenstein, Bernd ^ab; Martin, Sonja ^ac; Giri, Pratyush ^ad; Scholl, Sebastian ^ae; Topp, Max S ^af; Jung, Wolfram ^ag; Vucinic, Vladan ^ah; Beck, Hans-Joachim ^ai; Kerkhoff, Andrea ^aj; Unger, Benjamin ^ak; Rank, Andreas ^al; Schroers, Roland ^am; zum Büschenfelde, Christian Meyer ^an; de Wit, Maike ^ao; Trautmann-Grill, Karolin ^ap; Kamper, Peter ^{z, aq}; Molin, Daniel ^{z, ar}; Kreissl, Stefanie ^as; Kaul, Helen ^{a, b, c, d}; von Tresckow, Bastian ^{a, b, c, d, m}; Borchmann, Sven ^{a, b, c, d}; Behringer, Karolin ^{a, b, c, d}; Fuchs, Michael ^{a, b, c, d}; Rosenwald, Andreas ^at; Klapper, Wolfram ^au; Eich, Hans-Theodor ^av; Baues, Christian ^aw; Zomas, Athanasios ^ax; Hallek, Michael ^{a, b, c}; Dietlein, Markus ^{ay, az}; Kobe, Carsten ^{ay, az}; Diehl, Volker ^{a, b, c, d}
Source:	In The Lancet 27 July-2 August 2024 404(10450):341-352
Database:	ScienceDirect